Antibody combination therapy targeting CD25, CD70 and CD8 reduces islet inflammation and improves glycaemia in diabetic model
Clinical and Experimental Immunology, 08/01/2012
Alkhamis T et al. – Antibody combination therapy that targets CD25, CD70 and CD8 results in decreased islet infiltration and improved blood glucose levels in NOD model with established diabetes.



